Citation: | SUN Zhuolin, LIU Jingwei, KUANG Changchun. Inhibitions and mechanisms of amygdalin in non-small cell lung cancer NCI-H1299 cell line invasion in vitro[J]. Journal of China Pharmaceutical University, 2016, 47(4): 479-482. DOI: 10.11665/j.issn.1000-5048.20160415 |
[1] |
Reck M,Popat S,Reinmuth N,et al.Metastatic non-small-cell lung cancer(NSCLC):ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25(Suppl 3):iii27-39.
|
[2] |
Bolarinwa IF,Orfila C,Morgan MR.Amygdalin content of seeds,kernels and food products commercially-available in the UK[J].Food Chemistry,2014,152:133-139.
|
[3] |
Makarevi 'c J,Rutz J,Juengel E,et al.Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2[J].PLoS One,2014,9(8):e105590.
|
[4] |
Niu G,Ye T,Qin L,et al.Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4[J].FASEB J,2015,29(1):131-140.
|
[5] |
Matsubara D,Kishaba Y,Yoshimoto T,et al.Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer[J].Pathol Int,2014,64(11):560-568.
|
[6] |
Song JL,Nigam P,Tektas SS,et al.MicroRNA regulation of Wnt signaling pathways in development and disease[J].Cell Signal,2015,27(7):1380-1391.
|
[7] |
Sulzmaier FJ,Jean C,Schlaepfer DD.FAK in cancer:mechanistic findings and clinical applications[J].Nat Rev Cancer,2014,14(9):598-610.
|
[8] |
Fumarola C,Bonelli MA,Petronini PG,et al.Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer[J].Biochem Pharmacol,2014,90(3):197-207.
|
[9] |
Calderaro J,Rebouissou S,de Koning L,et al.PI3K/AKT pathway activation in bladder carcinogenesis[J].Int J Cancer,2014,134(8):1776-1784.
|
[10] |
Liu Y,Wang TT,Chen L.Synthesis and antitumor activity of isosteviol derivatives[J].J China Pharm Univ(中国药科大学学报),2016,47(1):48-53.
|
[1] | SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803 |
[2] | CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301 |
[3] | WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501 |
[4] | HE Junjin, WANG Jiayi, HAO Jingchao, CHENG Haoran, XU Hanmei. Antitumor effect of peptide mPEG-SC20k-HM-3 and oxaliplatin combination against human hepatocellular carcinoma SMMC-7721 in nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(4): 476-480. DOI: 10.11665/j.issn.1000-5048.20150415 |
[5] | CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206 |
[6] | HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105 |
[7] | YANG Yong-fang, YAN Hai-qiang, DING Guo-fang, HUANG Fang-fang. Isolation and purification of an anticancer activity peptide from protein hydrolysate of Mytilus coruscus[J]. Journal of China Pharmaceutical University, 2011, 42(3): 272-275. |
[8] | Research of anti-tumor peptide neutralizing antibodies activities[J]. Journal of China Pharmaceutical University, 2010, 41(2): 171-174. |
[9] | Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10. |
[10] | Studies on the Antitumor Principles of Herba Artemisiae capillaris[J]. Journal of China Pharmaceutical University, 1992, (5): 283-286. |